Overweight and/or ObesityPSYCOG-HIIENCT07276308
Psychophysiological and Cognitive Responses to Low-Volume High-Intensity Interval Exercise in Overweight-to-Obese Adults
A study testing Low-Volume High-Intensity Interval Exercise (Lv-HIIE) in people with Overweight and/or Obesity and Overweight and Obese Adults, run by Universiti Sains Malaysia at 1 site in Malaysia.
Trial summary
This study aims to explore how stress-related hormones and psychological traits influence people's feelings and perceptions during a short and intense form of exercise called low-volume high-intensity interval exercise (Lv-HIIE). Read more about this study
- Who is it for?
- Ages 20 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Overweight and/or Obesity, Overweight and Obese Adults
- What is being tested?
- Low-Volume High-Intensity Interval Exercise (Lv-HIIE)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteMalaysia
- Study dates
- 1 Mar 2023to 1 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male and female between the ages of 20-35 years old
- BMI of 23 kg.m² to 30 kg.m2
- Medically fit to exercise.
- Physically inactive individuals (do not achieve 150 minutes of moderate-intensity exercise/PA for a week).
Who cannot join
- smokers.
- free from any metabolic diseases such as hypertension, dyslipidaemia, and hyperglycaemia.
- not using any medication or substance known to influence cardiorespiratory or metabolic responses to exercise
- previously participated in a specific training program within the past 6 months before the exercise interventions.
- contraindications to exercise based on the Physical Activity Readiness Questionnaire (PAR-Q) such as musculoskeletal injuries.
Trial locations and contacts
1 site in 1 country.
Malaysia1 site
Universiti Sains Malaysia, Health Campus, Complex sports center
Kota Bharu, Kelantan, 16150
About this study
Official title: The Roles of Psychophysiological Stress and Cognitive Markers on Perceptual Responses During Low-volume High-intensity Interval Exercise in Overweight-to-obese Adults
This study aims to explore how stress-related hormones and psychological traits influence people's feelings and perceptions during a short and intense form of exercise called low-volume high-intensity interval exercise (Lv-HIIE). Adults with overweight or obesity participated in a supervised 10-week cycling program consisting of repeated one-minute high-intensity efforts separated by short recovery periods.
The research examines how psychophysiological stress markers (such as cortisol and ACTH), cognitive traits (such as goal orientation and hardiness), and perceptual responses (such as exertion, mood, and enjoyment) change over time. Findings from this study may help develop exercise programs that are more enjoyable, sustainable, and personalized for individuals with higher body-mass categories.
- Being tested
- Low-Volume High-Intensity Interval Exercise (Lv-HIIE)
- Keywords
- Exercise, Psychophysiological Stress, Cognitive traits, Affective Responses, High-Intensity Interval Exercise, Perceptual Responses
- Medical subject headings
- Overweight, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low-Volume High-Intensity Interval Exercise (Lv-HIIE)Behavioural
Also called Lv-HIIE Training, Low-Volume HIIE, High-Intensity Interval Exercise Program
The intervention consists of a supervised low-volume high-intensity interval exercise (Lv-HIIE) program performed on a cycle ergometer. Each session includes 6-10 intervals of 1 minute at 90% of maximal aerobic speed, interspersed with 75-second active recovery periods. Participants will train three times per week for 10 weeks under laboratory supervision. Each session begins with a standardized 5-minute warm-up and ends with a 5-minute cool-down. The program is designed to investigate changes in psychophysiological stress (ACTH, cortisol), cognitive markers (goal orientation, hardiness), and perceptual responses (affective valence, perceived exertion, enjoyment) across repeated exercise exposures in overweight-to-obese adults.
| Study group | Role | What they receive |
|---|---|---|
| Low-Volume High-Intensity Interval Exercise (Lv-HIIE) | Experimental | Participants will perform a low-volume high-intensity interval exercise (Lv-HIIE) program consisting of 6-10 cycling intervals at 90% of maximal aerobic speed, interspersed with 75-second active recovery periods. The intervention will be conducted three times per week for 10 weeks under supervised laboratory conditions. Each session will include standardized warm-up and cool-down phases. The study aims to evaluate psychophysiological stress, cognitive markers, and perceptual responses across repeated exercise sessions in overweight-to-obese adults. Receives: Behavioral: Low-Volume High-Intensity Interval Exercise (Lv-HIIE) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Outcome Measure: Height
Standing height will be measured using a stadiometer with participants barefoot and standing in the anatomical position. The value used for analysis will be the height recorded at baseline (Session 1).Unit of Measure: centimeters (cm)
Measured: Baseline only (Session 1)
Outcome Measure: Body Weight
Body weight will be measured using a calibrated digital scale with participants wearing light clothing and no shoes. The value used for analysis will be the body weight recorded at baseline (Session 1).Unit of Measure: kilograms (kg)
Measured: Session 1 (Week 0), Session 15 (Week 5), Session 30 (Week 10)
Outcome Measure: Body Mass Index (BMI)
BMI will be calculated using height and weight measured at baseline, using the formula BMI = weight (kg) / height (m²). The final reported value will be the BMI calculated at Session 1.Unit of Measure: kg/m²
Measured: Session 1 (Week 0), Session 15 (Week 5), Session 30 (Week 10)
Change in Affective Valence During Low-Volume High-Intensity Interval Exercise
Affective valence is assessed using the Feeling Scale (range -5 to +5) during each low-volume high-intensity interval exercise (Lv-HIIE) session, which consists of 6-10 cycles of 60 s shuttle running and 75 s active recovery. Affective valence is measured 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in Feeling Scale score from Session 1 to Session 30, with Session 15 serving as a mid-intervention reference time point.Feeling Scale score (-5 to +5)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Change in Felt Arousal During Low-Volume High-Intensity Interval Exercise
Felt arousal is assessed using the Felt Arousal Scale (range 1 to 6) during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). Felt arousal is measured 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in Felt Arousal Scale score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Felt Arousal Scale score (1-6)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Change in Rating of Perceived Exertion During Low-Volume High-Intensity Interval Exercise
Rating of perceived exertion (RPE) is measured using the Borg 6-20 scale during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). RPE is recorded 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in RPE from Session 1 to Session 30, with Session 15 as a mid-intervention reference point.Borg RPE score (6-20)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Change in Perceived Recovery During Low-Volume High-Intensity Interval Exercise
Perceived recovery is assessed using the Perceived Recovery Scale (range 0 to 10) during Lv-HIIE sessions. It is measured immediately after each 75-second active recovery interval in every cycle during Sessions 1, 15, and 30. The reported value will be the mean change in Perceived Recovery Scale score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Perceived Recovery Scale score (0-10)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Change in Exercise Enjoyment During Low-Volume High-Intensity Interval Exercise
Exercise enjoyment is assessed using a validated enjoyment scale (range 1 to 7) at the end of the Lv-HIIE session. Enjoyment is measured once at the end of Sessions 1, 15, and 30. The reported value will be the change in enjoyment score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Enjoyment scale score (total 126 scores)
Measured: Measured at the end of Sessions 1, 15, and 30 over 10 weeks
Change in Heart Rate During Low-Volume High-Intensity Interval Exercise
Heart rate is measured continuously and summarized at specific time points (5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down) during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). Heart rate is recorded during Sessions 1, 15, and 30. The reported value will be the mean change in heart rate (beats per minute) from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Beats per minute (bpm)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Change in Heart Rate Recovery During Low-Volume High-Intensity Interval Exercise
Heart rate recovery is assessed as heart rate measured immediately after each 75-second active recovery interval during Lv-HIIE sessions. Heart rate recovery is recorded for all cycles in Sessions 1, 15, and 30. The reported value will be the mean change in heart rate recovery (beats per minute during recovery periods) from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Beats per minute (bpm)
Measured: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Psychophysiological Stress (Blood Biomarkers)
Psychophysiological stress will be assessed using venous blood biomarkers. Blood samples will be collected at three predefined assessment days during the 10-week intervention: Day 1 (Week 1, baseline), Day 15 (Week 5), and Day 30 (Week 10, final assessment).
At each assessment day, venous blood will be drawn at three standardized time points:
Immediately before exercise (pre-exercise) Immediately after exercise (0 minutes post-exercise) 30 minutes post-exercise This results in nine total blood draws per participant. Biomarkers include cortisol, ACTH, and related stress markers. Changes will be compared across these assessment days.Concentration (pg/mL or ng/mL)
Measured: Day 1 (Week 1, baseline), Day 15 (Week 5), and Day 30 (Week 10, final assessment), with samples collected pre-exercise, immediately post-exercise, and 30 minutes post-exercise
Goal Orientation in Exercise Measure (GOEM) Total Score
Goal orientation will be assessed using the Goal Orientation in Exercise Measure (GOEM), a validated 10-item questionnaire scored on a 5-point Likert scale (1-5). Item scores are summed to produce a total GOEM score ranging from 0 to 50. The questionnaire is completed once at baseline, before the first training session, to characterize individual differences in goal-orientation tendencies that may influence perceptual and physiological responses during the intervention. The reported value will be the total GOEM score.Score range 0-50
Measured: Baseline (Day 1, before the first training session)
Connor-Davidson Resilience Scale (CDRS) Total Score
Psychological resilience will be assessed using the Connor-Davidson Resilience Scale (CDRS), a validated resilience questionnaire producing a total score ranging from 0 to 100. The scale is administered once at baseline, prior to the first training session, to evaluate individual differences in resilience traits that may influence perceptual and physiological responses during the intervention. The reported value will be the total CDRS score.Score range 0-100
Measured: Baseline (Day 1, before the first training session)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2025
- Study start1 Mar 2023
- Primary completion20 Aug 2023
- Study completion1 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Overweight and/or ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universiti Sains Malaysia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ruohan Zhang, Universiti Sains Malaysia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07276308
- Sponsor's protocol ID
- USM/JEPeM/22080549
- Other IDs
- FRGS/1/2022/SKK06/USM/03/5
- Acronym
- PSYCOG-HIIE
- Status last verified
- Dec 2025
- First submitted
- 14 Nov 2025
- Last updated
- 11 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Roles of Psychophysiological Stress and Cognitive Markers on Perceptual Responses During Low-volume High-intensity Interval Exercise in Overweight-to-obese Adults
- ClinicalTrials.gov ID
- NCT07276308
- Acronym / sponsor ID
- PSYCOG-HIIE / USM/JEPeM/22080549
- Keywords
- Exercise, Psychophysiological Stress, Cognitive traits, Affective Responses, High-Intensity Interval Exercise, Perceptual Responses
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Universiti Sains MalaysiaUniversity, hospital or other
- Study start
- 1 Mar 2023 (actual)
- Primary completion
- 20 Aug 2023 (actual)
- Study completion
- 1 Sep 2023 (actual)
- First posted
- 11 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to explore how stress-related hormones and psychological traits influence people's feelings and perceptions during a short and intense form of exercise called low-volume high-intensity interval exercise (Lv-HIIE). Adults with overweight or obesity participated in a supervised 10-week cycling program consisting of repeated one-minute high-intensity efforts separated by short recovery periods.
The research examines how psychophysiological stress markers (such as cortisol and ACTH), cognitive traits (such as goal orientation and hardiness), and perceptual responses (such as exertion, mood, and enjoyment) change over time. Findings from this study may help develop exercise programs that are more enjoyable, sustainable, and personalized for individuals with higher body-mass categories.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Low-Volume High-Intensity Interval Exercise (Lv-HIIE) | Experimental | Behavioral: Low-Volume High-Intensity Interval Exercise (Lv-HIIE)Participants will perform a low-volume high-intensity interval exercise (Lv-HIIE) program consisting of 6-10 cycling intervals at 90% of maximal aerobic speed, interspersed with 75-second active recovery periods. The intervention will be conducted three times per week for 10 weeks under supervised laboratory conditions. Each session will include standardized warm-up and cool-down phases. The study aims to evaluate psychophysiological stress, cognitive markers, and perceptual responses across repeated exercise sessions in overweight-to-obese adults. |
Who may qualify
- Ages
- 20 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Male and female between the ages of 20-35 years old
- BMI of 23 kg.m² to 30 kg.m2
- Medically fit to exercise.
- Physically inactive individuals (do not achieve 150 minutes of moderate-intensity exercise/PA for a week).
Key exclusion criteria (5 listed)
- smokers.
- free from any metabolic diseases such as hypertension, dyslipidaemia, and hyperglycaemia.
- not using any medication or substance known to influence cardiorespiratory or metabolic responses to exercise
- previously participated in a specific training program within the past 6 months before the exercise interventions.
- contraindications to exercise based on the Physical Activity Readiness Questionnaire (PAR-Q) such as musculoskeletal injuries.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low-Volume High-Intensity Interval Exercise (Lv-HIIE)Also: Lv-HIIE Training, Low-Volume HIIE, High-Intensity Interval Exercise ProgramThe intervention consists of a supervised low-volume high-intensity interval exercise (Lv-HIIE) program performed on a cycle ergometer. Each session includes 6-10 intervals of 1 minute at 90% of maximal aerobic speed, interspersed with 75-second active recovery periods. Participants will train three times per week for 10 weeks under laboratory supervision. Each session begins with a standardized 5-minute warm-up and ends with a 5-minute cool-down. The program is designed to investigate changes in psychophysiological stress (ACTH, cortisol), cognitive markers (goal orientation, hardiness), and perceptual responses (affective valence, perceived exertion, enjoyment) across repeated exercise exposures in overweight-to-obese adults. | Behavioural | Low-Volume High-Intensity Interval Exercise (Lv-HIIE) |
Primary outcome
Outcome Measure: Height
Time frame: Baseline only (Session 1)
Standing height will be measured using a stadiometer with participants barefoot and standing in the anatomical position. The value used for analysis will be the height recorded at baseline (Session 1).Unit of Measure: centimeters (cm)
Outcome Measure: Body Weight
Time frame: Session 1 (Week 0), Session 15 (Week 5), Session 30 (Week 10)
Body weight will be measured using a calibrated digital scale with participants wearing light clothing and no shoes. The value used for analysis will be the body weight recorded at baseline (Session 1).Unit of Measure: kilograms (kg)
Outcome Measure: Body Mass Index (BMI)
Time frame: Session 1 (Week 0), Session 15 (Week 5), Session 30 (Week 10)
BMI will be calculated using height and weight measured at baseline, using the formula BMI = weight (kg) / height (m²). The final reported value will be the BMI calculated at Session 1.Unit of Measure: kg/m²
Change in Affective Valence During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Affective valence is assessed using the Feeling Scale (range -5 to +5) during each low-volume high-intensity interval exercise (Lv-HIIE) session, which consists of 6-10 cycles of 60 s shuttle running and 75 s active recovery. Affective valence is measured 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in Feeling Scale score from Session 1 to Session 30, with Session 15 serving as a mid-intervention reference time point.Feeling Scale score (-5 to +5)
Change in Felt Arousal During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Felt arousal is assessed using the Felt Arousal Scale (range 1 to 6) during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). Felt arousal is measured 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in Felt Arousal Scale score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Felt Arousal Scale score (1-6)
Change in Rating of Perceived Exertion During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Rating of perceived exertion (RPE) is measured using the Borg 6-20 scale during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). RPE is recorded 5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down during Sessions 1, 15, and 30. The reported value will be the mean change in RPE from Session 1 to Session 30, with Session 15 as a mid-intervention reference point.Borg RPE score (6-20)
Change in Perceived Recovery During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Perceived recovery is assessed using the Perceived Recovery Scale (range 0 to 10) during Lv-HIIE sessions. It is measured immediately after each 75-second active recovery interval in every cycle during Sessions 1, 15, and 30. The reported value will be the mean change in Perceived Recovery Scale score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Perceived Recovery Scale score (0-10)
Change in Exercise Enjoyment During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at the end of Sessions 1, 15, and 30 over 10 weeks
Exercise enjoyment is assessed using a validated enjoyment scale (range 1 to 7) at the end of the Lv-HIIE session. Enjoyment is measured once at the end of Sessions 1, 15, and 30. The reported value will be the change in enjoyment score from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Enjoyment scale score (total 126 scores)
Change in Heart Rate During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Heart rate is measured continuously and summarized at specific time points (5 minutes before exercise, 20 seconds before the end of warm-up, immediately after each 60-second work interval, and after cool-down) during Lv-HIIE sessions (6-10 cycles of 60 s work + 75 s active recovery). Heart rate is recorded during Sessions 1, 15, and 30. The reported value will be the mean change in heart rate (beats per minute) from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Beats per minute (bpm)
Change in Heart Rate Recovery During Low-Volume High-Intensity Interval Exercise
Time frame: Measured at every training session (Sessions 1-30) over 10 weeks; primary analysis compares Sessions 1, 15, and 30
Heart rate recovery is assessed as heart rate measured immediately after each 75-second active recovery interval during Lv-HIIE sessions. Heart rate recovery is recorded for all cycles in Sessions 1, 15, and 30. The reported value will be the mean change in heart rate recovery (beats per minute during recovery periods) from Session 1 to Session 30, with Session 15 as a mid-intervention reference.Beats per minute (bpm)
Psychophysiological Stress (Blood Biomarkers)
Time frame: Day 1 (Week 1, baseline), Day 15 (Week 5), and Day 30 (Week 10, final assessment), with samples collected pre-exercise, immediately post-exercise, and 30 minutes post-exercise
Psychophysiological stress will be assessed using venous blood biomarkers. Blood samples will be collected at three predefined assessment days during the 10-week intervention: Day 1 (Week 1, baseline), Day 15 (Week 5), and Day 30 (Week 10, final assessment). At each assessment day, venous blood will be drawn at three standardized time points: Immediately before exercise (pre-exercise) Immediately after exercise (0 minutes post-exercise) 30 minutes post-exercise This results in nine total blood draws per participant. Biomarkers include cortisol, ACTH, and related stress markers. Changes will be compared across these assessment days.Concentration (pg/mL or ng/mL)
Goal Orientation in Exercise Measure (GOEM) Total Score
Time frame: Baseline (Day 1, before the first training session)
Goal orientation will be assessed using the Goal Orientation in Exercise Measure (GOEM), a validated 10-item questionnaire scored on a 5-point Likert scale (1-5). Item scores are summed to produce a total GOEM score ranging from 0 to 50. The questionnaire is completed once at baseline, before the first training session, to characterize individual differences in goal-orientation tendencies that may influence perceptual and physiological responses during the intervention. The reported value will be the total GOEM score.Score range 0-50
Connor-Davidson Resilience Scale (CDRS) Total Score
Time frame: Baseline (Day 1, before the first training session)
Psychological resilience will be assessed using the Connor-Davidson Resilience Scale (CDRS), a validated resilience questionnaire producing a total score ranging from 0 to 100. The scale is administered once at baseline, prior to the first training session, to evaluate individual differences in resilience traits that may influence perceptual and physiological responses during the intervention. The reported value will be the total CDRS score.Score range 0-100
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2025.
Related trials for Overweight and/or Obesity
Not yet recruitingPhase 2
A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes
Overweight or Obese Participants Without Diabetes
Active, not recruitingPhase 1
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
Healthy Volunteers, Overweight or Obesity
RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Active, not recruitingPhase 3
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
Obesity & Overweight
Active, not recruitingPhase 1
A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity
Overweight, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low-Volume High-Intensity Interval Exercise (Lv-HIIE) in people with Overweight and/or Obesity and Overweight and Obese Adults, run by Universiti Sains Malaysia at 1 site in Malaysia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Outcome Measure: Height (time frame: Baseline only (Session 1)). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2025.